return

In addition, an industry

Posted by: DingLiTime: 2018-03-23

In an interview with Securities Daily, Shi Li-chen, the founder of the third-party medical service platform, said in the interview with the Securities Daily in 2017 that the performance of enterprises in the pharmaceutical industry in 2017 will be in general performance. In 2018, with the full implementation of the two-vote system, Drug bidding, the second bargaining and other sets of portfolio policy under the influence of the drug prices are expected to further reduce the use of non-therapeutic drugs further restricted the performance of enterprises will be even more bleak.In an interview with Securities Daily, Shi Li-chen, the founder of the third-party medical service platform, said in the interview with the Securities Daily in 2017 that the performance of enterprises in the pharmaceutical industry in 2017 will be in general performance. In 2018, with the full implementation of the two-vote system, Drug bidding, the second bargaining and other sets of portfolio policy under the influence of the drug prices are expected to further reduce the use of non-therapeutic drugs further restricted the performance of enterprises will be even more bleak.In an interview with Securities Daily, Shi Li-chen, the founder of the third-party medical service platform, said in the interview with the Securities Daily in 2017 that the performance of enterprises in the pharmaceutical industry in 2017 will be in general performance. In 2018, with the full implementation of the two-vote system, Drug bidding, the second bargaining and other sets of portfolio policy under the influence of the drug prices are expected to further reduce the use of non-therapeutic drugs further restricted the performance of enterprises will be even more bleak.